Quest Diagnostics (DGX) Equity Income (2009 - 2026)

Quest Diagnostics (DGX) has 18 years of Equity Income data on file, last reported at $4.0 million in Q1 2026.

• Quarterly Equity Income fell 77.78% year-over-year to $4.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $28.0 million (down 3.45% YoY) and the FY2025 annual result came in at $42.0 million, up 121.05% from the prior year.
• Equity Income retreated to $4.0 million in Q1 2026 per DGX's latest filing, from $7.0 million in the prior quarter.
• The five-year high for Equity Income was $31.0 million in Q1 2022, with the low at $3.0 million in Q4 2022.
• Average Equity Income over 5 years is $8.4 million, with a median of $6.5 million recorded in 2022.
• Year-over-year, Equity Income tumbled 88.0% in 2022 and soared 166.67% in 2023.
• Quest Diagnostics' Equity Income stood at $3.0 million in 2022, then soared by 166.67% to $8.0 million in 2023, then sank by 37.5% to $5.0 million in 2024, then surged by 40.0% to $7.0 million in 2025, then sank by 42.86% to $4.0 million in 2026.
• Business Quant data shows DGX's Equity Income at $4.0 million in Q1 2026, $7.0 million in Q4 2025, and $8.0 million in Q3 2025.